01:13 PM EDT, 04/10/2026 (MT Newswires) -- Health care stocks declined Friday afternoon, with the NYSE Health Care Index decreasing 0.7% and the State Street Health Care Select Sector SPDR ETF (XLV) falling 1.2%.

The iShares Biotechnology ETF (IBB) dropped 1.8%.

In corporate news, Replimune's ( REPL ) shares tumbled 19%. The company's biologics license application for vusolimogene oderparepvec to treat unresectable advanced cutaneous melanoma was rejected by the US Food and Drug Administration, the regulator said in a complete response letter.